Madrigal Pharmaceuticals, Inc. MDGL Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s shares (basic)?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported shares (basic) of 29M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s shares (basic) changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s shares (basic) increased by 3.4% year-over-year, from 28.1M to 29M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s shares (basic)?
- Over 4 years (2021 to 2025), Madrigal Pharmaceuticals, Inc.'s shares (basic) has grown at a 14.4% compound annual growth rate (CAGR), from 66.1M to 113.2M.
- What does shares (basic) mean?
- The average number of common shares held by investors throughout the reporting period.
- How do you interpret shares (basic)?
- An increase suggests share issuance, which may dilute existing shareholders, while a decrease suggests share buybacks.
- How does shares (basic) compare across companies?
- Used by analysts to track equity financing activities and capital structure changes relative to industry peers.